YCM
ITOS

Yousif Capital Management’s iTeos Therapeutics ITOS Stock Holding History

Yousif Capital Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-21,143
Closed -$232K – 1994
2023
Q3 		$232K Sell
21,143
-15
-0.1% -$192 ﹤0.01% 1798
2023
Q2 		$280K Sell
21,158
-914
-4% -$13K ﹤0.01% 1737
2023
Q1 		$300K Sell
22,072
-2,130
-9% -$38.2K ﹤0.01% 1695
2022
Q4 		$473K Buy
24,202
+1,915
+9% +$37.4K 0.01% 1521
2022
Q3 		$425K Buy
22,287
+2,708
+14% +$62.4K 0.01% 1584
2022
Q2 		$403K Buy
19,579
+715
+4% +$17K 0.01% 1628
2022
Q1 		$607K Buy
+18,864
New +$685K 0.01% 1562

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Yousif Capital Management's ITOS Position: Q4 2023 in Review

Yousif Capital Management sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 21,143 shares — an estimated $232K sold.

Yousif Capital Management first reported a position in ITOS in Q1 2022 and held it in 7 quarters. The position peaked at $607K in Q1 2022. 137 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Yousif Capital Management reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Yousif Capital Management sold 21,143 iTeos Therapeutics shares in Q4 2023, an estimated $232K.
  • Yousif Capital Management first reported a position in iTeos Therapeutics in Q1 2022 and held it in 7 quarters.
  • Yousif Capital Management's iTeos Therapeutics position peaked at $607K in Q1 2022.
  • 137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Yousif Capital Management's 13F filing for Q4 2023, filed 1 Feb 2024.